MedTrace Logo

Fibromyalgia and Sexual Functıonal Dısorder and Sexual Therapy

NCT05272345 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2024-07-18

No results posted yet for this study

Summary

investigators aim to re-evaluate the findings of Fibromyalgia in patients whose FSFI scores return to normal levels after sexual therapy, by identifying patients with sexual dysfunction according to the FSFI scale applied in patients investigators followed up with a diagnosis of fibromyalgia, and when investigators consulted with obstetricians.

Conditions

  • Fibromyalgia
  • Sexual Dysfunction

Interventions

PROCEDURE

sexual therapy

In sexual therapy; A total of 4 sessions of therapy were initiated with the patients, one session per week for 1 month.

Sponsors & Collaborators

  • Kanuni Sultan Suleyman Training and Research Hospital

    lead OTHER

Principal Investigators

  • Pınar Kadiroğulları · Acıbadem University Atakent Hospital

Study Design

Allocation
NA
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
15 Years
Max Age
49 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-02-14
Primary Completion
2024-05-14
Completion
2025-12-14

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05272345 on ClinicalTrials.gov